Watch Ticker

Belite Bio, Inc American Depositary Shares

Go to Belite Bio, Inc American Depositary Shares Website

$66.31

0.00 (0.00%)

Live

Previous Close

$66.31

Day Range

$0 - $0

Previous Day Range

$64.85 - $69.09

Market Cap

$2.3 billion USD

Day Vol.

Previous Day Vol.

43552

Currency

USD

Primary Exchange

Nasdaq

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive St...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Belite Bio - Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy

Belite Bio completed enrollment in a global Phase 3 trial evaluating Tinlarebant, an oral medication for treating geographic atrophy in dry age-related macular degeneration, with 500 subjects across 8 countries.

Related tickers: BLTE.

Read Full Article

N/A - International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 15, 2025

Deutsche Bank is hosting a virtual investor conference on May 15, 2025, featuring live webcasts from various international companies with American Depositary Receipt (ADR) programs in the United States.

Related tickers: VIOT, CLCGY, HCM, COE, YRD, BLTE, IH, BVNRY, ABBNY, EPOAY, BDOUY.

Read Full Article

Trending Tickers

Please sign in to view